AAAAAA

   
Results: 1-14 |
Results: 14
Effects of an antibody to vascular endothelial growth factor receptor-2 onsurvival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis
Authors: Shaheen, RM Tseng, WW Vellagas, R Liu, WB Ahmad, SA Jung, YD Reinmuth, N Drazan, KE Bucana, CD Hicklin, DJ Ellis, LM
Citation: Rm. Shaheen et al., Effects of an antibody to vascular endothelial growth factor receptor-2 onsurvival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis, INT J ONCOL, 18(2), 2001, pp. 221-226
Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival
Authors: Reinmuth, N Liu, WB Jung, YD Ahmad, SA Shaheen, RM Fan, F Bucana, CD McMahon, G Gallick, GE Ellis, LM
Citation: N. Reinmuth et al., Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival, FASEB J, 15(7), 2001, pp. 1239-1241
Overview of angiogenesis: Biologic implications for antiangiogenic therapy
Authors: Ellis, LM Liu, WB Ahmad, SA Fan, F Jung, YD Shaheen, RM Reinmuth, N
Citation: Lm. Ellis et al., Overview of angiogenesis: Biologic implications for antiangiogenic therapy, SEMIN ONCOL, 28(5), 2001, pp. 94-104
The effects of angiopoietin-1 and-2 on tumor growth and angiogenesis in human colon cancer
Authors: Ahmad, SA Liu, WB Jung, YD Fan, F Wilson, M Reinmuth, N Shaheen, RM Bucana, CD Ellis, LM
Citation: Sa. Ahmad et al., The effects of angiopoietin-1 and-2 on tumor growth and angiogenesis in human colon cancer, CANCER RES, 61(4), 2001, pp. 1255-1259
Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms
Authors: Shaheen, RM Tseng, WW Davis, DW Liu, WB Reinmuth, N Vellagas, R Wieczorek, AA Ogura, Y McConkey, DJ Drazan, KE Bucana, CD McMahon, G Ellis, LM
Citation: Rm. Shaheen et al., Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms, CANCER RES, 61(4), 2001, pp. 1464-1468
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
Authors: Shaheen, RM Ahmad, SA Liu, W Reinmuth, N Jung, YD Tseng, WW Drazan, KE Bucana, CD Hicklin, DJ Ellis, LM
Citation: Rm. Shaheen et al., Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors, BR J CANC, 85(4), 2001, pp. 584-589
Endothelial cell survival and apoptosis in the tumor vasculature
Authors: Liu, W Ahmad, SA Reinmuth, N Shaheen, RM Jung, YD Fan, F Ellis, LM
Citation: W. Liu et al., Endothelial cell survival and apoptosis in the tumor vasculature, APOPTOSIS, 5(4), 2000, pp. 323-328
Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent
Authors: Mendel, DB Laird, AD Smolich, BD Blake, RA Liang, CX Hannah, AL Shaheen, RM Ellis, LM Weitman, S Shawver, LK Cherrington, JM
Citation: Db. Mendel et al., Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent, ANTI-CAN DR, 15(1), 2000, pp. 29-41
Role of the tumor microenvironment in mediating response to anti-angiogenic therapy
Authors: Jung, YD Ahmad, SA Akagi, Y Takahashi, Y Liu, W Reinmuth, N Shaheen, RM Fan, F Ellis, LM
Citation: Yd. Jung et al., Role of the tumor microenvironment in mediating response to anti-angiogenic therapy, CANC METAST, 19(1-2), 2000, pp. 147-157
Vascular endothelial growth factor is an in vivo survival factor for tumorendothelium in a murine model of colorectal carcinoma liver metastases
Authors: Bruns, CJ Liu, WB Davis, DW Shaheen, RM McConkey, DJ Wilson, MR Bucana, CD Hicklin, DJ Ellis, LM
Citation: Cj. Bruns et al., Vascular endothelial growth factor is an in vivo survival factor for tumorendothelium in a murine model of colorectal carcinoma liver metastases, CANCER, 89(3), 2000, pp. 488-499
Presentation and pretreatment evaluation of patients with adenocarcinoma of the colon
Authors: Shaheen, RM Edelstein, PS
Citation: Rm. Shaheen et Ps. Edelstein, Presentation and pretreatment evaluation of patients with adenocarcinoma of the colon, PROT GEN S, 2000, pp. 137-156
Vascular endothelial growth factor levels and induction of permeability inmalignant pleural effusions
Authors: Zebrowski, BK Yano, S Liu, WB Shaheen, RM Hicklin, DJ Putnam, JB Ellis, LM
Citation: Bk. Zebrowski et al., Vascular endothelial growth factor levels and induction of permeability inmalignant pleural effusions, CLIN CANC R, 5(11), 1999, pp. 3364-3368
Antiangiogenic therapy targeting the tyrosine kinase receptor for vascularendothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis
Authors: Shaheen, RM Davis, DW Liu, WB Zebrowski, BK Wilson, MR Bucana, CD McConkey, DJ McMahon, G Ellis, LM
Citation: Rm. Shaheen et al., Antiangiogenic therapy targeting the tyrosine kinase receptor for vascularendothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis, CANCER RES, 59(21), 1999, pp. 5412-5416
Regulation of vascular endothelial growth factor expression in human coloncancer by interleukin-1 beta
Authors: Akagi, Y Liu, W Xie, K Zebrowski, B Shaheen, RM Ellis, LM
Citation: Y. Akagi et al., Regulation of vascular endothelial growth factor expression in human coloncancer by interleukin-1 beta, BR J CANC, 80(10), 1999, pp. 1506-1511
Risultati: 1-14 |